In E7GRG + 2’-3’cGAMP+CpG-C-treated tumor-bearing mice, the tumor growth was markedly suppressed, accompanied by the enhanced lymphocyte proliferation response, Th1 cytokine profile, CD8+ T-cell responses, granzyme B production, and antibody responses (14). This evidence concerns the gene CD8A and neoplasm.